Brick & Kyle Associates’s NeoGenomics NEO Stock Holding History

Brick & Kyle Associates’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-9,000	Closed	-$71K	–	260
2017 Q1	$71K	Hold	9,000	–	–	0.06%	146
2016 Q4	$77K	Hold	9,000	–	–	0.06%	141
2016 Q3	$74K	Hold	9,000	–	–	0.06%	145
2016 Q2	$72K	Hold	9,000	–	–	0.06%	151
2016 Q1	$61K	Hold	9,000	–	–	0.05%	157
2015 Q4	$71K	Hold	9,000	–	–	0.06%	143
2015 Q3	$52K	Hold	9,000	–	–	0.05%	164
2015 Q2	$49K	Hold	9,000	–	–	0.04%	178
2015 Q1	$42K	Hold	9,000	–	–	0.04%	194
2014 Q4	$38K	Buy	+9,000	New	+$41.4K	0.03%	200

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Brick & Kyle Associates's NEO Position: Q2 2017 in Review

Brick & Kyle Associates sold out of NeoGenomics (NEO) in Q2 2017, closing a stake of 9,000 shares — an estimated $71K sold.

Brick & Kyle Associates first reported a position in NEO in Q4 2014 and held it in 10 quarters. The position peaked at $77K in Q4 2016. 134 funds tracked by Wall St. Rank hold NEO as of Q2 2017.

Brick & Kyle Associates reported no remaining NeoGenomics position as of Q2 2017 after selling out during the quarter.
Brick & Kyle Associates sold 9,000 NeoGenomics shares in Q2 2017, an estimated $71K.
Brick & Kyle Associates first reported a position in NeoGenomics in Q4 2014 and held it in 10 quarters.
Brick & Kyle Associates's NeoGenomics position peaked at $77K in Q4 2016.
134 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2017.

Based on Brick & Kyle Associates's 13F filing for Q2 2017, filed 14 Aug 2017.